Literature DB >> 22970025

microRNA signature for human pancreatic cancer invasion and metastasis.

He Cheng1, Si Shi, Xiaochen Cai, Jiang Long, Jin Xu, Chen Liu, Xianjun Yu.   

Abstract

Pancreatic cancer has the poorest prognosis among all human malignant solid tumors, mainly due to its high invasive and metastatic biological features. microRNAs (miRNAs) are a group of endogenous and small non-coding RNA molecules 18-25 nucleotides in length, functioning as either tumor-suppressor genes or oncogenes. Evidence has shown that regulation of miRNAs in pancreatic cancer is associated with tumor growth, invasion, metastasis and resistance to therapy. Over the last decade, many studies have also found that there is a close relationship between miRNAs and biological characteristics of pancreatic cancer invasion and metastasis, such as the presence of cancer stem cells, epithelial-mesenchymal transition (EMT) phenotype, DNA methylation or epigenetic alteration, and the activation of some specific signaling pathways. Therefore, better understanding of the complex role of miRNAs in the development and progression of pancreatic cancer metastasis may provide new insights that could be of therapeutic consequence. In this brief review, we discuss the literature concerning the correlation between miRNAs and pancreatic cancer, focusing on miRNAs that contribute to pancreatic cancer invasion and metastasis, particularly on cancer stem cell characteristics, the EMT process, epigenetic modifications and tumor-associated signaling pathways.

Entities:  

Year:  2012        PMID: 22970025      PMCID: PMC3439005          DOI: 10.3892/etm.2012.585

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  87 in total

1.  DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

Authors:  Sripathi M Sureban; Randal May; Stan A Lightfoot; Aimee B Hoskins; Megan Lerner; Daniel J Brackett; Russell G Postier; Rama Ramanujam; Altaf Mohammed; Chinthalapally V Rao; James H Wyche; Shrikant Anant; Courtney W Houchen
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

2.  Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas.

Authors:  Randal May; Sripathi M Sureban; Stan A Lightfoot; Aimee B Hoskins; Daniel J Brackett; Russell G Postier; Rama Ramanujam; Chinthalapally V Rao; James H Wyche; Shrikant Anant; Courtney W Houchen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

Review 3.  Molecular pathogenesis of pancreatic cancer and clinical perspectives.

Authors:  D Matthaios; P Zarogoulidis; I Balgouranidou; E Chatzaki; S Kakolyris
Journal:  Oncology       Date:  2011-11-23       Impact factor: 2.935

4.  Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells.

Authors:  Taiki Moriyama; Kenoki Ohuchida; Kazuhiro Mizumoto; Lin Cui; Naoki Ikenaga; Norihiro Sato; Masao Tanaka
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

5.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

Authors:  Mark Bloomston; Wendy L Frankel; Fabio Petrocca; Stefano Volinia; Hansjuerg Alder; John P Hagan; Chang-Gong Liu; Darshna Bhatt; Cristian Taccioli; Carlo M Croce
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

6.  Altered MicroRNA expression in cervical carcinomas.

Authors:  Jeong-Won Lee; Chel Hun Choi; Jung-Joo Choi; Young-Ae Park; Seung-Jun Kim; Seung Yong Hwang; Woo Young Kim; Tae-Joong Kim; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

7.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

8.  Control of antagonistic components of the hedgehog signaling pathway by microRNAs in Drosophila.

Authors:  Florence Friggi-Grelin; Laurence Lavenant-Staccini; Pascal Therond
Journal:  Genetics       Date:  2008-05       Impact factor: 4.562

9.  Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

Authors:  Yiwei Li; Timothy G VandenBoom; Dejuan Kong; Zhiwei Wang; Shadan Ali; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

10.  Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

Authors:  Valery Tarasov; Peter Jung; Berlinda Verdoodt; Dmitri Lodygin; Alexey Epanchintsev; Antje Menssen; Gunter Meister; Heiko Hermeking
Journal:  Cell Cycle       Date:  2007-05-11       Impact factor: 4.534

View more
  13 in total

Review 1.  Targeting microRNAs in pancreatic cancer: microplayers in the big game.

Authors:  Sheema Khan; Deepak Kumar; Meena Jaggi; Subhash C Chauhan
Journal:  Cancer Res       Date:  2013-11-07       Impact factor: 12.701

2.  MicroRNA-103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c-Myb.

Authors:  Jinlong Liang; Xianfeng Liu; Hongpeng Xue; Bing Qiu; Bin Wei; Kan Sun
Journal:  Cell Prolif       Date:  2014-12-22       Impact factor: 6.831

Review 3.  Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.

Authors:  Umashankar K Ballehaninna; Ronald S Chamberlain
Journal:  Tumour Biol       Date:  2013-08-17

Review 4.  Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review).

Authors:  Ramadevi Subramani; Laxman Gangwani; Sushmita Bose Nandy; Arunkumar Arumugam; Munmun Chattopadhyay; Rajkumar Lakshmanaswamy
Journal:  Int J Oncol       Date:  2015-08-21       Impact factor: 5.650

5.  Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis.

Authors:  Ramadevi Subramani; Rebecca Lopez-Valdez; Arunkumar Arumugam; Sushmita Nandy; Thiyagarajan Boopalan; Rajkumar Lakshmanaswamy
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

Review 6.  Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers.

Authors:  Björn L D M Brücher; Yan Li; Philipp Schnabel; Martin Daumer; Timothy J Wallace; Rainer Kube; Bruno Zilberstein; Scott Steele; Jan L A Voskuil; Ijaz S Jamall
Journal:  Clin Transl Med       Date:  2016-04-06

7.  Extensive cutaneous metastases of pancreatic adenocarcinoma: a case report and review of the literature.

Authors:  Ioannis Kotsantis; Panagiota Economopoulou; Konstantinos Dritsakos; Nikolaos Oikonomopoulos; Marios Bakogeorgos; Cleopatra Rapti; Nikolaos Kentepozidis
Journal:  Clin Case Rep       Date:  2016-12-20

8.  Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.

Authors:  Zherui Wu; Daniel Martinez-Fong; Jean Trédaniel; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-17       Impact factor: 5.555

9.  Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients.

Authors:  Rui Zhang; Shangen Zheng; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Guoqiang Zhao
Journal:  Diagn Pathol       Date:  2014-03-18       Impact factor: 2.644

Review 10.  MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?

Authors:  Oronzo Brunetti; Antonio Russo; Aldo Scarpa; Daniele Santini; Michele Reni; Alessandro Bittoni; Amalia Azzariti; Giuseppe Aprile; Sabina Delcuratolo; Michele Signorile; Antonio Gnoni; Loredana Palermo; Vito Lorusso; Stefano Cascinu; Nicola Silvestris
Journal:  Oncotarget       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.